Home » Topics » Conferences

Conferences
RSS

New dihydrofolate reductase inhibitors with antitumor and antiparasitic activities

June 17, 1998

DiavaX potential for vaccination against diabetes shown in preclinical models

June 16, 1998

Alexion presents antidiabetic fusion protein at ADA meeting

June 16, 1998

Eprosartan: overview of clinical pharmacology

June 16, 1998

Head-to-head comparison of the antihypertensive effects of an NEP/ACE inhibitor and an ACE inhibitor

June 16, 1998

Insulin sensitizers profiled at ADA meeting

June 16, 1998

NOX-101 protects against endothelial dysfunction in diabetic rats

June 16, 1998

Tanabe's selective SGLT inhibitor shows potential for diabetes Rx

June 16, 1998

GA-0113, a new-generation angiotensin II antagonist with clinical potential

June 15, 1998

More on Exocell's antiglycation agent EXO-226

June 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...